Credit Suisse’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$6.59M Buy
117,505
+6,201
+6% +$348K 0.01% 1145
2023
Q4
$6.7M Buy
111,304
+29,964
+37% +$1.8M 0.01% 1156
2023
Q3
$5.46M Sell
81,340
-1,582
-2% -$106K 0.01% 1211
2023
Q2
$5.72M Buy
82,922
+9,203
+12% +$635K 0.01% 1238
2023
Q1
$3.55M Buy
73,719
+9,228
+14% +$445K ﹤0.01% 1516
2022
Q4
$3.22M Sell
64,491
-5,100
-7% -$255K ﹤0.01% 1588
2022
Q3
$2.84M Sell
69,591
-46,488
-40% -$1.9M ﹤0.01% 1601
2022
Q2
$6.39M Sell
116,079
-19,899
-15% -$1.09M 0.01% 1132
2022
Q1
$4.94M Buy
135,978
+26,154
+24% +$950K ﹤0.01% 1442
2021
Q4
$5.12M Buy
109,824
+92,981
+552% +$4.33M ﹤0.01% 1492
2021
Q3
$852K Buy
16,843
+2,466
+17% +$125K ﹤0.01% 2685
2021
Q2
$590K Sell
14,377
-2,116
-13% -$86.8K ﹤0.01% 2932
2021
Q1
$478K Buy
16,493
+3,318
+25% +$96.2K ﹤0.01% 2979
2020
Q4
$371K Buy
+13,175
New +$371K ﹤0.01% 3077